A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
University Hospital, Angers
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
NeoTX Therapeutics Ltd.
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
SOLTI Breast Cancer Research Group
Molecular Templates, Inc.
Western Sydney Local Health District
Jules Bordet Institute
Institut Bergonié
Xencor, Inc.
Incyte Corporation
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Shenzhen BinDeBio Ltd.
Masonic Cancer Center, University of Minnesota
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)